CAS 23674-86-4
:Epitopic
- (6Alpha,11Beta)-21-(Acetyloxy)-6,9-Difluoro-11-Hydroxy-3,20-Dioxopregna-1,4-Dien-17-Yl Butanoate
- (6Alpha,8Xi,10Xi,11Beta,13Xi)-21-(Acetyloxy)-6,9-Difluoro-11-Hydroxy-3,20-Dioxopregna-1,4-Dien-17-Yl Butanoate
- (6α,11β)-21-(Acetyloxy)-6,9-difluoro-11-hydroxy-17-(1-oxobutoxy)pregna-1,4-diene-3,20-dione
- 21-(Acetyloxy)-6,9-difluoro-11-hydroxy-17-(1-oxobutoxy)pregna-1,4-diene-3,20-dione (6alpha,11beta)-
- 6-Alpha,9α-difluoroprednisolone 21-acetate 17-butyrate
- 6-alpha,9-alpha-Difluoroprednisolone 17-butyrate 21-acetate
- 6a,9-Difluoro-11β,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-acetate 17-butyrate
- 6alpha,9-Difluoro-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-acetate 17-butyrate
- 6alpha-9-Difluoroprednisolone 21-acetate 17-butyrate
- 6α,9-Difluoroprednisolone 21-acetate 17-butyrate
- 6α,9α-Difluoroprednisolone 21-acetate 17-butyrate
- Butyric acid, 17-ester with 6α,9-difluoro-11β,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-acetate
- Cm 9155
- Difluprednato
- Difluprednato [INN-Spanish]
- Difluprednatum
- Difluprednatum [INN-Latin]
- Durezol
- Epitopic
- Myser
- Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-6,9-difluoro-11-hydroxy-17-(1-oxobutoxy)-, (6alpha,11beta)-
- Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-6,9-difluoro-11-hydroxy-17-(1-oxobutoxy)-, (6α,11β)-
- Pregna-1,4-diene-3,20-dione, 6-alpha,9-difluoro-11-beta,17,21-trihydroxy-, 21-acetate, 17-butyrate
- Pregna-1,4-diene-3,20-dione, 6α,9-difluoro-11β,17,21-trihydroxy-, 21-acetate 17-butyrate
- Unii-S8A06Qg2Qe
- W 6309
- See more synonyms
(6α,11β)-21-(Acetyloxy)-6,9-difluoro-11-hydroxy-17-(1-oxobutoxy)pregna-1,4-diene-3,20-dion
CAS:Formula:C27H34F2O7Purity:98%Color and Shape:SolidMolecular weight:508.5515Difluprednate
CAS:Formula:C27H34F2O7Purity:≥ 98.0%Color and Shape:White powderMolecular weight:508.55Difluprednate-d3
CAS:Formula:C27H31D3F2O7Color and Shape:White To Off-White SolidMolecular weight:511.58Difluprednate
CAS:Formula:C27H34F2O7Purity:>98.0%(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:508.56Difluprednate
CAS:Difluprednate (Myser)(Durezol) is a corticosteroid, approved for the treatment of post-operative ocular inflammation and pain.
Formula:C27H34F2O7Purity:99.23% - 99.86%Color and Shape:SolidMolecular weight:508.55Difluprednate
CAS:Controlled ProductApplications A corticosteroid (derivative of prednisolone), approved for the treatment of post-operative ocular inflammation.
References Kapp, A., et al.: J. Allergy and Clin. Immunol., 110, 277 (2002), Yasueda, S., et al.: J. Pharm. Biomed. Anal., 30, 1735 (2003), Yamaguchi, M., et al.: Int. J. Pharm., 301, 121 (2005),Formula:C27H34F2O7Color and Shape:WhiteMolecular weight:508.55Difluprednate-d3
CAS:Controlled ProductFormula:C27D3H31F2O7Color and Shape:NeatMolecular weight:511.57Difluprednate
CAS:Controlled ProductDifluprednate is a corticosteroid that is used topically to treat eye inflammation. It has been shown to reduce ocular inflammation in rats and mice, with no effect on the cornea. Difluprednate is prepared as an aqueous solution containing benzalkonium chloride, which acts as a preservative. The medication can be used for short periods of time, but prolonged use may lead to bowel disease and polymerase chain reactions. Difluprednate has anti-inflammatory activity and can be used in place of nonsteroidal anti-inflammatory drugs (NSAIDs). It has been found that prednisolone acetate, the active form of difluprednate, inhibits inflammatory cells in vitro by inhibiting nuclear factor kappaB activation. This inhibition leads to decreased production of pro-inflammatory cytokines and chemokines such as IL-1β, IL-6, IL-8, T
Formula:C27H34F2O7Purity:Min. 95%Color and Shape:White PowderMolecular weight:508.55 g/molDifluprednate
CAS:Halogenated derivatives of adrenal cortical hormonesFormula:C27H34F2O7Molecular weight:508.22726










